| Website | allostera.com/abo... |
| Category | BioTech |
| Employees | |
| Description | Biopharmaceutical Company |
| Series C, 7/09 iNovia Capital Genesys Capital BDC Venture Capital GO Capital Fund | $15.4M |
Allostera Pharma is a preclinical-stage biopharmaceutical company focused on autoimmune diseases such as psoriatic arthritis, gout and type II diabetes.